The World Health Organization's director reports that five patients have recovered from a rare type of Ebola virus in eastern Congo, where a new treatment center has opened.

The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove ...

The World Health Organization reports that five patients have recovered from a rare type of Ebola in eastern Congo ...

In an editorial published in the New England Journal of Medicine, University of Michigan Health hepatologist Anna S. Lok, M.D., hails newly announced results of the B-Well clinical trials as "a major ...

A first-of-its-kind drug has provided a "functional cure" in about 20% of patients with chronic hepatitis B infections, providing a possible lifeline for sufferers on Long Island, which has the ...

ExThera claimed its blood filters could treat cancer but several patients say the procedure worsened their conditions and even contributed to deaths.

The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) driven by EGFR ...

NexusHealth has an extensive ecosystem of experts – including innovation and commercialization leaders at McMaster – in all ...

HIV patients can be drug-free for up to two years under a treatment that ends the need for daily pills. A new antibody ...

A new drug has cured 20% of patients with a chronic, cancer-causing disease — which was previously incurable. A viral ...

Inmazeb ® (a three-antibody cocktail consisting of maftivimab, atoltivimab and odesivimab-ebgn) was the first Ebola treatment approved by the ...